His research activities are directly linked to these two topics. The first line of research focuses on improving existing neuromodulatory treatments and developing novel therapies for neurodegenerative disorders. The second line of research aims to develop biological markers predicting the disease course and surgical outcome of skull base tumors such as chordomas and vestibular schwannomas.